Tag Archives: Immuno Oncology

BIO Investor Forum Session on Advancing Immuno–Oncology

At the 2016 BIO Investor Forum, the first session held was titled “The Intersection of Inflammation and Immuno-Oncology: Risks and Opportunities.” Moderated by Michael King, Managing Director and Senior Research Analyst at JMP Securities, panelist included: Jay Venkatesan, MD, President & Director, Alpine Immune Sciences Pablo Cagnoni, MD, President & Chief Executive Officer, Tizona Therapeutics Alex Szidon, PhD, Executive Director, Business Development & Licensing; Head of West Coast Innovation Hub, Merck & Co. Inc. Paul Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Immuno Oncology – A 30-year Overnight Success Story

Photo Feb 11, 1 30 16 PM

“It was the Rodney Dangerfield space – couldn’t get no respect” One would never guess those words were used to describe immuno-oncology, a field that has recently bloomed into full-fledged frenzy – with private companies raising unprecedented Series As, impressive data being announced and Science designating the field “Breakthrough of the Year” all in 2013. Yet Dr. Jeffrey Weber, an early member in the “i-onc” research community likened the past several decades of immuno-oncology to Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,